Epigral Ltd Clarifies Volume Movement to Stock Exchange

Epigral Limited has responded to a clarification sought by BSE Limited regarding an increase in the company's trading volume. The company stated that it has made all necessary disclosures as per SEBI regulations, including all price-sensitive information and events impacting operations or performance. Epigral Limited affirmed that no material information has been withheld. The company attributes the recent movement in volume and share price to general market conditions and market-driven factors, asserting no direct connection from the company's side to these movements. They will continue to comply with disclosure requirements within stipulated timelines.